Cough and Cold Preparations Market in Argentina to 2014 (OTC Healthcare)
Global Site License: US$ 875.00
Introduction
This databook provides key data and information on the Cough and Cold Preparations Market in Argentina (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.
Scope
The cough and cold preparations category was valued at ARS95.9m ($30.5m) in 2009, representing a CAGR of 13.3% since 2004.
By the end of 2014, the cough and cold preparations category will be worth ARS109.2m ($34.7m), with an expected CAGR of 2.6% between 2009 and 2014.
The cough and cold preparations market was led by mixtures (representing 33.8% of the total value) followed by tablets and topical remedies, with a 27.4% and 24.8% market share, respectively. Lozenges accounts for the remaining 14% share.
Bayer AG is the market leader with a 33.3% share of the market.
Reasons to Purchase
Introduction
This databook provides key data and information on the Cough and Cold Preparations Market in Argentina (OTC Healthcare). This report is a comprehensive resource for market, category and segment level data including value, volume, distribution share and company & brand share. This report also provides expenditure and consumption data for the historic and forecast periods.
Scope
- Market,category and segment level information on value, volume, and expenditure & consumption, with historic (2003-2008) and forecast (2009-2013) data
- Category level company and brand share as well as distribution share information for 2007 and 2008
The cough and cold preparations category was valued at ARS95.9m ($30.5m) in 2009, representing a CAGR of 13.3% since 2004.
By the end of 2014, the cough and cold preparations category will be worth ARS109.2m ($34.7m), with an expected CAGR of 2.6% between 2009 and 2014.
The cough and cold preparations market was led by mixtures (representing 33.8% of the total value) followed by tablets and topical remedies, with a 27.4% and 24.8% market share, respectively. Lozenges accounts for the remaining 14% share.
Bayer AG is the market leader with a 33.3% share of the market.
Reasons to Purchase
- Develop business strategies by understanding the quantitative trends within the Cough and Cold Preparations Market in Argentina (OTC Healthcare)
- Design effective marketing and sales strategies by identifying key market categories and segments
- Identify key players within the market to plan lucrative M&A, partnerships and agreements
Contents
CHAPTER 1 EXECUTIVE SUMMARYSummary category level: cough and cold preparations
CHAPTER 2 DEFINITION
Market definition
CHAPTER 3 CATEGORY ANALYSIS: COUGH AND COLD PREPARATIONS
Value analysis (Argentine Peso), 2004−09
Value analysis (Argentine Peso), 2009−14
Value analysis (US dollars), 2004−09
Value analysis (US dollars), 2009−14
Company and brand share analysis
Distribution analysis
CHAPTER 4 MACROECONOMIC PROFILE
Macroeconomic Indicators
CHAPTER 5 RESEARCH METHODOLOGY
Methodology overview
Secondary research
Market modeling
Creating an initial data model
Revising the initial data model
Creating a final estimate
Creating demographic value splits
Primary research
Data finalization
Ongoing research
LIST OF FIGURES
Figure 1: Cough and cold preparations, Argentina, value by segment (ARSm), 2004−14
Figure 2: Cough and cold preparations, Argentina, category growth comparison, by value, 2004−14
Figure 3: Cough and cold preparations, Argentina, company share by value (%), 2008−09
Figure 4: Cough and cold preparations, Argentina, distribution channels by value (%), 2008−09
Figure 5: Annual data review process
LIST OF TABLES
Table 1: Cough and cold preparations category definitions
Table 2: Cough and cold preparations distribution channels
Table 3: Cough and cold preparations, Argentina, value by segment (ARSm), 2004−09
Table 4: Cough and cold preparations, Argentina, value forecast by segment (ARSm), 2009−14
Table 5: Cough and cold preparations, Argentina, value by segment ($m), 2004−09
Table 6: Cough and cold preparations, Argentina, value forecast by segment ($m), 2009−14
Table 7: Cough and cold preparations, Argentina, brand share by value (%), 2008−09
Table 8: Cough and cold preparations, Argentina, value by brand (ARSm), 2008−09
Table 9: Cough and cold preparations, Argentina, company share by value (%), 2008−09
Table 10: Cough and cold preparations, Argentina, value by company (ARSm), 2008−09
Table 11: Cough and cold preparations, Argentina, distribution channels by value (%), 2008−09
Table 12: Cough and cold preparations, Argentina, value by distribution channel (ARSm), 2008−09
Table 13: Argentina population, by age group, 2004−09 (millions)
Table 14: Argentina population forecast, by age group, 2009−14 (millions)
Table 15: Argentina population, by gender, 2004−09 (millions)
Table 16: Argentina population forecast, by gender, 2009−14 (millions)
Table 17: Argentina nominal GDP, 2004−09 (ARSbn, nominal prices)
Table 18: Argentina nominal GDP forecast, 2009−14 (ARSbn, nominal prices)
Table 19: Argentina real GDP, 2004−09 (ARSbn, 2000 prices)
Table 20: Argentina real GDP forecast, 2009−14 (ARSbn, 2000 prices)
Table 21: Argentina real GDP, 2004−09 ($bn, 2000 prices)
Table 22: Argentina real GDP forecast, 2009−14 ($bn, 2000 prices)
Table 23: Argentina consumer price index, 2004−09 (2000=100)
Table 24: Argentina consumer price index, 2009−14 (2000=100)
Skip to top